IBRX

ImmunityBio, Inc.

Biological Products, (No Diagnostic Substances)NasdaqLarge accelerated filer

Total Trades

11

Buys

3

Sells

5

Largest Trade

N/A

Insiders

5

Institutional Funds

228

Inst. Value

$1M+

Activist Filings

6

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Simon Barry J.DirectorSELL$500K+75K$12.01Feb 27, 2026
Selecky ChristobelDirectorEXERCISE$50K–$100K25K$2.98Feb 25, 2026
Selecky ChristobelDirectorSELL$100K–$500K25K$10.00Feb 25, 2026
Simon Barry J.DirectorEXERCISEN/A15KFeb 25, 2026
Simon Barry J.DirectorSELL$1M+175K$10.19Feb 25, 2026
Simon Barry J.DirectorSELL$1M+152K$7.20Jan 22, 2026
Selecky ChristobelDirectorSELL$100K–$500K75K$5.84Jan 22, 2026
Selecky ChristobelDirectorEXERCISE$100K–$500K75K$2.98Jan 22, 2026
BLASZYK MICHAEL DDirectorBUY$100K–$500K72K$2.75Jun 6, 2023
Brennan John OwenDirectorBUY$50K–$100K25K$2.83Jun 5, 2023
Clark WesleyDirectorBUY$15K–$50K7K$2.91Jun 5, 2023
🔓Seeing ranges? Sign in for exact trade values — free forever

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Cambridge Equities, LP

SC 13D/A · Feb 26, 2026

25.5%

261.7M shares

Cambridge Equities, LP

SC 13D/A · Nov 11, 2025

26.6%

261.7M shares

Cambridge Equities, LP

SC 13D/A · Jan 4, 2024

39.0%

261.7M shares

Cambridge Equities, LP (2)

SC 13D/A · Sep 21, 2023

39.2%

261.7M shares

Cambridge Equities, LP

SC 13D/A · May 22, 2023

60.0%

261.7M shares

Cambridge Equities, LP

SC 13D/A · Dec 7, 2022

65.4%

261.7M shares

View on Google Finance →